{name}
{subtitle}
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
city
~17 mi. (Ocotlán de Juárez, Mexico, +89 more cities)
facility
Centro de Investigacion Clinica de Oaxaca
biomarker
ER Positive, +1 more biomarker
drug
giredestrant, +1 more drug
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
city
~17 mi. (Ocotlán de Juárez, Mexico, +383 more cities)
facility
Centro de Investigacion Clinica de Oaxaca
biomarker
ER Negative, +2 more biomarkers
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +1 more type
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
city
~17 mi. (Ocotlán de Juárez, Mexico, +260 more cities)
facility
Centro de Investigacion Clinica de Oaxaca
biomarker
ERBB2 Amplification, +1 more biomarker
drug type
immunotherapy, +1 more type